Hims & Hers Health stock

HIMS · NYSE · USD

Compare Hims & Hers Health
$14.60Change from previous close: −8.86%Absolute change: −$1.42

Close · November 20, 2026

Price history

−56.57% over the period

1 year: from $33.62 (November 20, 2025) to $14.60 (November 20, 2026), −56.57%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026$14.60
October 30, 2026$27.68
September 30, 2026$29.79
August 31, 2026$29.58
July 31, 2026$27.77
June 30, 2026$34.67
May 29, 2026$26.15
April 30, 2026$27.17
March 31, 2026$20.76
February 27, 2026$14.52
January 30, 2026$27.09
December 31, 2025$32.47
November 28, 2025$39.76
November 20, 2025$33.62

At a glance

  • The company

    Consumer-first health and wellness platform connecting consumers to licensed healthcare professionals and offering prescription, non-prescription, and OTC products

  • Latest results

    Quarter to September 30, 2026 · EPS -$0.14 (estimate $0.06)

TickerLandia's take on Hims & Hers Health

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$13.74
52-wk high$40.99

−64.38% from the 52-week high

Analysts · 15 analysts

Average target$27.23+86.51% vs. price

Buy 4 · Hold 11 · Sell 0 · Hold

TickerLandia Fingerprint: Hims & Hers Health

Compared with similar companies: very weak momentum, very high risk, and very low earnings stability.

Financials and price compared with 39 companies in the drug manufacturers - specialty & generic industry, worldwide. Momentum and risk compared with 888 North American stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Hims & Hers Health is pricier than similar companies

Hims & Hers Health's Forward P/E: 48.7, +249% against the median of a group of 11 similar companies (14.0).

Compared with 11 similar companies

Hims & Hers Health's metrics compared with similar companies
MetricHims & Hers HealthPosition in the groupBand
Forward P/E48.7High
Operating margin-6.4%Low
ROE-40.8%Low
Debt/equity4.39High
Price/book9.63High

Grey band: the middle half of the group; tick: the median; dot: Hims & Hers Health. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

$890.37M

Latest quarter · Q3 2026

Net income

-$33.04M

Latest quarter · Q3 2026

Quarterly net margin

-3.7%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
$3.42B
EPS
-$0.83
Volume
16.06M
Daily trading
€322.98M
Dividend yield
0.00%

How Hims & Hers Health is changing

All results
  • Revenue grew 73.6% a year on average over the last 5 years

  • Operating margin rose from −12.6% to 5.2%

  • Profits turn into cash: free cash flow equal to 147% of net income

Returns

Hims & Hers Health returns

$1,000 invested in Hims & Hers Health 5 years ago, on November 22, 2021, would be worth $2,042 today: +104.20% in total, +15.37% per year. This is the price return only: dividends are excluded.

PeriodHims & Hers HealthS&P 500$1,000 becomes
1 month−50.02%−10.40%$500
6 months−36.63%−7.03%$634
Year to date−55.04%+0.95%$450
1 year−56.57%+5.68%$434
3 years+88.63%+51.96%$1,886
5 years+104.20%+47.57%$2,042

Over the last 6 months it has done better than 4% of the stocks in the Healthcare sector.

Price only, without dividends. Calculate your investment

The chart in detail

Hims & Hers Health: technical analysis

Hims & Hers Health shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 78.8% below its all-time closing high ($68.74, February 19, 2025).

Trend
No clear trend
RSI (14 sessions)
25
Below 30: a strong fall in a short time
vs 200-session average
−44.82%

Active signals

  • Close below the low of the previous 55 sessions.

    since November 17, 2026

  • RSI below 30: the stock has fallen a lot in a short time.

    since November 17, 2026

  • The last session opened more than 3% below the previous close.

Support and resistance

Price areas where Hims & Hers Health has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance$31.97+118.96%4 touches, last on October 12, 2026
  2. Resistance$30.26+107.28%6 touches, last on October 29, 2026
  3. Resistance$27.21+86.36%6 touches, last on October 15, 2026
  4. Last price$14.60
  5. No support below: the price is near the lows of the year

Volatility and risk

Over the last year it has moved more than the S&P 500.

Beta (1 year) vs S&P 500
2.64
Volatility (60 sessions, annualised)
82.2%
Largest fall in the last year
−63.72%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Hims & Hers Health: seasonality

Average monthly price change over 8 years

+9.9%Jan+6.6%Feb+1.1%Mar+1.9%Apr+15.9%May+2.8%Jun+3.4%Jul−11.6%Aug+7.0%Sep−7.3%Oct+18.8%Nov−0.1%Dec

Over the last 8 years, the strongest month for Hims & Hers Health has been November: +18.79% on average, positive in 5 years out of 7. The weakest has been August: −11.60% on average, positive in 3 years out of 7.

Show chart data
MonthAverageMedianPositive years
January+9.90%+1.52%4 of 7
February+6.60%+6.97%4 of 7
March+1.10%−0.38%3 of 7
April+1.85%−0.30%3 of 7
May+15.89%−0.37%3 of 7
June+2.85%+3.96%5 of 7
July+3.43%+1.28%4 of 7
August−11.60%−0.38%3 of 7
September+7.00%+0.71%4 of 7
October−7.30%−6.01%2 of 8
November+18.79%+3.14%5 of 7
December−0.15%0.00%3 of 7

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Hims & Hers Health and its competitors

Based in San Francisco, California, Hims & Hers Health, Inc. has existed since 2017 as a consumer health and wellness platform that links customers with licensed healthcare professionals. Prescription and non-prescription products are sold through its websites, mobile application, retail partners and stores, alongside medical consultations and laboratory testing. Under the Hims & Hers brand, it offers over-the-counter drugs, devices, cosmetics and supplements for skincare, sexual health, hair care and general wellness, plus treatments for chronic conditions in hormone health, weight loss, dermatology and mental health.

Headquarters
San Francisco, United States
Employees
2,442
Founded
2017
Chief executive
Andrew Dudum
Hims & Hers Health and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Hims & Hers HealthHIMS$3.42B-6.4%—−36.63%
Neurocrine BiosciencesNBIX$15.24B26.6%22.3−2.65%
ViatrisVTRS$22.5B11.5%—+18.32%
United TherapeuticsUTHR$23.63B39.4%20.9−1.63%
ZoetisZTS$32.14B37.9%13.5−0.75%
Teva Pharmaceutical IndustriesTEVA$45.77B19.8%91.2+14.31%

Same industry or related industries, similar size. Compare Hims & Hers Health with its competitors · Full profile